SD Biosensor, Inc.
Research SD Biosensor, Inc. (137310.KS) on Bullrun: market cap KRW 809.82B, dividend yield 3.0%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker137310.KS
- ExchangeKS
- CountrySouth Korea
- SectorHealthcare
- IndustryMedical Devices
- CurrencyKRW
- Market capKRW 809.82B
- Dividend yield3.0%
- Financial periodQ2 2026
- RevenueKRW 186.48B
- Net incomeKRW 16.46B
- Free cash flow-KRW 7.48B
- Gross margin49.6%
Valuation Snapshot
latest market cap is KRW 809.82B; dividend yield is 3.0%.
Peer valuation comparison
Latest dividend yield is 2.95% versus a Healthcare sector median of 2.4% (22.9% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 809.82B | n/a | 3.0% | 200 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 200 KRW, yield 3.0%.
About SD Biosensor, Inc.
SD Biosensor, Inc., together with its subsidiaries, operates as an in-vitro diagnostic company in South Korea, India, Asia, Europe, the Americas, and Africa. The company offers STANDARD Q, which provides rapid diagnostic products; STANDARD F, a fluorescence immunodiagnostic system for various qualitative and quantitative diagnosis items; STANDARD E, an enzyme immunoassay diagnosis for large-volume tests;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is SD Biosensor, Inc.'s market cap?
SD Biosensor, Inc.'s market capitalization is KRW 809.82B.
Does SD Biosensor, Inc. pay a dividend?
SD Biosensor, Inc. has a dividend yield of 3.0%.
What does SD Biosensor, Inc. do?
SD Biosensor, Inc., together with its subsidiaries, operates as an in-vitro diagnostic company in South Korea, India, Asia, Europe, the Americas, and Africa. The company offers STANDARD Q, which provides rapid diagnostic products; STANDARD F, a fluorescence immunodiagnostic system for various qualitative and quantitative diagnosis items; STANDARD E, an enzyme immunoassay diagnosis for large-volume tests; and STANDARD M, a field molecular diagnosis system for infectious disease diagnosis, drug resistance, and genetic testing.